SC
PFE icon

Sapient Capital’s Pfizer PFE Stock Holding History

Sapient Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3M Sell
427,068
-24,770
-5% -$648K 0.13% 82
2026
Q1 		$12.7M Sell
451,838
-22,939
-5% -$611K 0.19% 75
2025
Q4 		$11.9M Sell
474,777
-10,439
-2% -$263K 0.17% 84
2025
Q3 		$11.6M Sell
485,216
-21,658
-4% -$535K 0.18% 82
2025
Q2 		$12.3M Sell
506,874
-9,735
-2% -$227K 0.22% 74
2025
Q1 		$13.1M Sell
516,609
-3,236
-0.6% -$84.7K 0.26% 71
2024
Q4 		$13.8M Sell
519,845
-447,066
-46% -$12.1M 0.26% 69
2024
Q3 		$28M Buy
966,911
+13,879
+1% +$405K 0.56% 41
2024
Q2 		$26.7M Buy
953,032
+6,334
+0.7% +$174K 0.56% 38
2024
Q1 		$26.3M Buy
946,698
+890,095
+1,573% +$24.7M 0.58% 39
2023
Q4 		$1.63M Buy
+56,603
New +$1.71M 0.04% 138

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sapient Capital's PFE Position: Q2 2026 in Review

Sapient Capital reduced its Pfizer (PFE) stake by 5.5% in Q2 2026, selling an estimated $648K and leaving 427,068 shares worth $10.3M. The position accounts for 0.13% of the portfolio, ranked #82.

Sapient Capital first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $28M in Q3 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Sapient Capital held 427,068 shares of Pfizer worth $10.3M as of Q2 2026.
  • Sapient Capital sold 24,770 Pfizer shares in Q2 2026, an estimated $648K.
  • Pfizer made up 0.13% of Sapient Capital's portfolio in Q2 2026, its #82 holding.
  • Sapient Capital first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Sapient Capital's Pfizer position peaked at $28M in Q3 2024.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.